Why the study?
Despite reported high in-hospital mortality for STEMI in Sub-Saharan Africa, follow-up data in these patients are scarce.
Does revascularization improve mortality and nonfatal cardiovascular complications in patients with STEMI in a Sub-Saharan African population?
Population
260 patients admitted for STEMI to Abidjan Heart Institute
Comparison
Revascularized vs non-revascularized patients
Design
Prospective cohort study
Follow-up
Median period of 39 months [28-68 months]
Authors
Loading...
STEMI mortality data from this African cohort warrant cautious interpretation; leaves open the need for targeted trials on reperfusion and predictors.
Does revascularization improve mortality and nonfatal cardiovascular complications in patients with STEMI in a Sub-Saharan African population?
In a Sub-Saharan African cohort of STEMI patients, revascularization was associated with significantly lower all-cause mortality over a median follow-up of 39 months.
Yao et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: